Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
56.7%
% of FBT's 31 holdings also in WDNA
20.0%
% of WDNA's 90 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 4.5% | 4.0% | 4.0% |
|
UNITED THERAPEUTICS CORP | 3.4% | 1.8% | 1.8% |
|
SAREPTA THERAPEUTICS INC | 3.4% | 1.6% | 1.6% |
|
ALNYLAM PHARMACEUTICALS INC | 2.8% | 1.5% | 1.5% |
|
GILEAD SCIENCES INC | 3.5% | 1.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to WDNA
|
EXELIXIS INC | 4.6% |
|
INTRA-CELLULAR THERAPIES INC | 4.2% |
|
NEUROCRINE BIOSCIENCES INC | 4.1% |
|
ACADIA PHARMACEUTICALS INC | 3.9% |
|
CORCEPT THERAPEUTICS INC | 3.7% |
|
CATALYST PHARMACEUTICAL PART | 3.6% |
|
INCYTE CORP | 3.6% |
|
WATERS CORP | 3.6% |
|
HALOZYME THERAPEUTICS INC | 3.3% |
 |
ALKERMES PLC | 3.2% |
FBT Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -3.8% |
 |
NOVOZYMES A/S-B SHARES | -3.5% |
|
VERICEL CORPORATION | -2.8% |
|
BLUEPRINT MEDICINES CORP. | -2.5% |
|
VERACYTE INC | -2.5% |
|
ELI LILLY & CO | -2.3% |
|
GERON CORP | -2.1% |
|
BRIDGEBIO PHARMA, INC. | -2.0% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.6% |